News & Updates
Filter by Specialty:
Autoantibodies against type 1 interferons increase COVID-19 death risk
The presence of autoantibodies neutralizing type 1 interferons (IFN), such as IFN-α2 or IFN-ω, strongly increase the relative risk of death (RRD) and infection fatality rate (IFR) in unvaccinated patients with COVID-19, according to a recent study.
Autoantibodies against type 1 interferons increase COVID-19 death risk
14 Jun 2022
Treatment outcomes for nAMD, DMO, RVO poorer in clinical practice than in trials
In clinical practice, patients with neovascular age-related macular degeneration (nAMD), diabetic macular oedema (DMO), and retinal vein occlusion (RVO) see treatment outcomes that are inferior to those reported in pivotal phase 3 studies, according to a recent study.
Treatment outcomes for nAMD, DMO, RVO poorer in clinical practice than in trials
13 Jun 2022
Infection + vaccination = The best protection against COVID-19?
Individuals with a prior COVID-19 infection and who are fully vaccinated against COVID-19 appear to have the greatest immunity to the virus, according to the SIREN* study.
Infection + vaccination = The best protection against COVID-19?
13 Jun 2022
CREATE: ‘Open-source’ automated insulin delivery gets good results in T1D
Automating insulin delivery with an open-source algorithm that is run on a smartphone proves safe and effective in the management of type 1 diabetes (T1D), as shown in the results of Community Derived Automated Insulin Delivery (CREATE) trial.
CREATE: ‘Open-source’ automated insulin delivery gets good results in T1D
13 Jun 2022
Limited health literacy tied to low knowledge on SLE
Limited health literacy among patients with systemic lupus erythematosus (SLE) contributes to lower knowledge about the disease, a study has shown. The Lupus Knowledge Assessment Test (LKAT) may be improved and used as a screening tool to identify those with knowledge gaps.